Advanced detection and accurate measurement (ADAM) residual white blood cell (RWBC) kits
Ended Purchase Order Awarded Last action
- Contract number
- HT941024P0198
- Awardee
-
Nanoentek America, Inc. UEI WKSAFWSWAZG5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $31,221
Award facts
- Opportunity
-
- Notice of Intent to Sole Source Annual Drop Shipments of NanoEntek America ADAM (Advanced Detection and Accurate Measurement) rWBC (residual White Blood Cell) Kits for U. S. Naval Hospital Okinawa, Japan Pre-Solicitation · HT941024N0094 · Posted Jul 9, 2024
- Contract value 40% obligated
-
- $31,221.12 Current, with exercised options
- $78,052.80 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Waltham, MA 02451, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $15,611 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $15,611 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a purchase order to Nanoentek America, Inc. for $78,052.80 on October 1, 2024, for ADAM Residual White Blood Cell (RWBC) kits and drop shipment services. Place of performance is Waltham, Massachusetts. The kits support government-owned NanoEntek rWBC cell counter equipment at United States Naval Hospital Okinawa, enabling the facility to provide leuko-reduced blood products to uniformed service personnel, dependents, and veterans across military treatment facilities in the Indo-Pacific region. Performance extends through September 3, 2029. The procurement originated from a pre-solicitation posted July 9, 2024, seeking firm fixed-price annual drop shipments of FDA-approved diagnostic kits under NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC 6550 (In Vitro Diagnostic Substances).
Quick answers
Who was awarded contract HT941024P0198?
HT941024P0198 was awarded to Nanoentek America, Inc. by Defense Health Agency (Department of Defense) on October 1, 2024.
How much is contract HT941024P0198 worth?
The government has obligated $31,221 on HT941024P0198. Its potential value, with all options, is $78,053.
Was contract HT941024P0198 competed?
The extent of competition for HT941024P0198 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award